ARCHIVES

Amgen Claimed QOL Benefit Despite FDA Label Change.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

ONS elects Officers, Presents Awards

June 4, 1993

Chabner Calls For Audit Of I-ELCAP Data, Full Financial Disclosure.

May 2, 2008

Proposed Deal Could Resolve Key Disputes At NSABP, Pitt

January 13, 1995

President Proposes $1 Billion Increase For NIH In FY2011; Cancer A High Priority

February 5, 2010

Longer List of DCPC Spending Plans $40 Mll Increase

December 10, 1993

NTP Board Oks Seven Compounds For Tests

April 22, 1983